<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220812055662N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-09-29</date_registration>
      <primary_sponsor>The University of Kharazmi</primary_sponsor>
      <public_title>The effect of eccentric exercises with gait retraining on reducing patellofemoral pain</public_title>
      <acronym></acronym>
      <scientific_title>The effect of adding eccentric exercises to gait retraining exercises on pain, kinetics and kinematics of runners with patellofemoral pain syndrome</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-10-08</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65229</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: After initial review, using the http://randomizer.org/ website, patients who have criteria for entering the study randomly participate in retraining، eccentric exercises and control groups. randomization will be simple type. hiding the random allocation using computer-generated randomized block table ( number 1 for retraining group, number 2 for eccentric exercises group and number 3 for control group ). The random numerical sequence is placed in non-transparent and sealed envelopes and will be opened by a third party and the treatment process will continue in accordance with the group's assignment. the evaluator will evaluate the results before the intervention and after 8 weeks of intervention, independent of the hypothesis and methods of the study, Blinding description: Participants read the consent form and present in a 30-minute session of the study groups then participate in this study with satisfaction, without the authority to select their group. the names of the patients are informed by a person unaware of the identity characteristics and Physically, patients randomly divided into three equal groups by / http://randomizer.org and each group is placed separately in sealed envelopes.
Each person receive own training and exercises according to their assigned group. the analyzer also examines and compares changes made before and after 8 weeks without knowing the hypotheses, study methods, and patient specifications.</study_design>
      <phase>N/A</phase>
      <hc_freetext>patellofemoral pain syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: This group performs gait retraining with verbal feedback. gait retraining done on a treadmill. People run on a treadmill at all times at a convenient speed. Verbal feedback in the form of a recipe such as "Knee retention in the direction of the toes, reduced pelvic sagging and maintaining pelvic symmetry، Decreasing vertical acceleration ( is provided by the tester: a quiet and calm walking style).In general, the practice time starts in 15 minutes for the first session and 3 to 9 minutes per week is added to the time. While the time of gait retaining is reduced from 100% in the first 4 weeks to 25% in the last weeks and then removed. Exercises are followed 3 days a week for 8 weeks. Intervention 2: Intervention group: this group, After performing the retraining group's practices, performs the protocol of the eccentric exercises. the participants will do the exercises correctly، The intensity of the exercises will increase progressively each week, and at the beginning of each stage, the exercises will be performed in a simpler and smaller volume، Step by step, more difficult exercises and less large exercises will be more difficult in the next steps, respectively, with the progress and improvement of the performance of the training athlete. In general, the practice time is 90 minutes, which is done after warm up and gait retraining. exercises are followed 3 days a week for 8 weeks. Intervention 3: Control group: This group continues their special routine exercises.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only data related to demographic information and consequences are shared.

When:
After printing the article / articles are arrogant from the study

To whom:
The data can be displayed and shared at the logical request of the Iranian Clinical Trials Registration Center, journals and academic researchers / researchers who are researching and conducting scientific activities in this field.

Conditions:
Data analysis and the use of documentation can only be done on the condition that their results be included in the systematic review articles conducted by researchers and academic authors. Terms of registration for sending data and documents including: 1. Send an email ( preferably with valid academic addresses ) to one of the study researchers. 2. Brief and logical explanation of how to use data or documentation. 3. Ensure the registration of a systematic review study protocol that has given access to data or documentation.

Where to obtain:
By requesting study researchers 
Elahe Omidvar Elahe.omidvar@khu.ac.ir
Malihe Hadadnezhad Malihehadadnezhad@khu.ac.ir
Amir Letafatkar Amir.letafatkar@khu.ac.ir

How to obtain:
The applicant can request details from the researchers within 7 to 10 days using the email sent by email.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amir Letafatkar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kharazmi university., Hesari Ave., Mirdamad St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1571914911</zip>
        <telephone>+98 21 2222 8001</telephone>
        <email>letafatkaramir@yahoo.com</email>
        <affiliation>The University of kharazmi</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Malihe Hadadnezhad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kharazmi university., Hesari Ave., Mirdamad St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1571914911</zip>
        <telephone>+98 21 2222 8001</telephone>
        <email>malihehadadnezhad@khu.ac.ir</email>
        <affiliation>The University of kharazmi</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Male and female runners with a continuous history of recreational sports in the last 3 years
18 to 40 years age group
Standard Body Mass Index between 20 –25
Patellofemoral pain syndrome with a history of 2 months and a intensity of 3 to 7 on a visual analog scale</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of lower and upper body damage in the past year
Lower body zone abnormalities
Surgery history in the lower limbs, especially the knee, before participating in the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M22.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Patellofemoral disorders</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: This group performs gait retraining with verbal feedback. gait retraining done on a treadmill. People run on a treadmill at all times at a convenient speed. Verbal feedback in the form of a recipe such as "Knee retention in the direction of the toes, reduced pelvic sagging and maintaining pelvic symmetry، Decreasing vertical acceleration ( is provided by the tester: a quiet and calm walking style).In general, the practice time starts in 15 minutes for the first session and 3 to 9 minutes per week is added to the time. While the time of gait retaining is reduced from 100% in the first 4 weeks to 25% in the last weeks and then removed. Exercises are followed 3 days a week for 8 weeks.</i_keyword>
      <i_keyword>Intervention group: this group, After performing the retraining group's practices, performs the protocol of the eccentric exercises. the participants will do the exercises correctly، The intensity of the exercises will increase progressively each week, and at the beginning of each stage, the exercises will be performed in a simpler and smaller volume، Step by step, more difficult exercises and less large exercises will be more difficult in the next steps, respectively, with the progress and improvement of the performance of the training athlete. In general, the practice time is 90 minutes, which is done after warm up and gait retraining. exercises are followed 3 days a week for 8 weeks.</i_keyword>
      <i_keyword>Control group: This group continues their special routine exercises.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: Before the intervention and after 8 weeks of intervention. Method of measurement: Pain questionnaire of Visual Analogue scale (VAS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Kinetic: Ground reaction force. Timepoint: Before the intervention and after 8 weeks of intervention. Method of measurement: Force plate.</sec_outcome>
      <sec_outcome>Kinematic: pelvic drop. Timepoint: Before the intervention and after 8 weeks of intervention. Method of measurement: Three-dimensional (3D) motion analysis system.</sec_outcome>
      <sec_outcome>Kinematic: hip adduction. Timepoint: Before the intervention and after 8 weeks of intervention. Method of measurement: Three-dimensional (3D) motion analysis system.</sec_outcome>
      <sec_outcome>Kinematic: knee flexion. Timepoint: Before the intervention and after 8 weeks of intervention. Method of measurement: Three-dimensional (3D) motion analysis system.</sec_outcome>
      <sec_outcome>Kinematic: knee valgus. Timepoint: Before the intervention and after 8 weeks of intervention. Method of measurement: Three-dimensional (3D) motion analysis system.</sec_outcome>
      <sec_outcome>Kinematic: dorsiflexion. Timepoint: Before the intervention and after 8 weeks of intervention. Method of measurement: Three-dimensional (3D) motion analysis system.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The University of Kharazmi</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-07-05</approval_date>
        <contact_name>Ethics committee of sport sciences Research Institute</contact_name>
        <contact_address>No. 45, Payande 5 Ave., Mosala 18 Blvd.,Rastgar St. Babol Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
